Teladoc Health, Inc.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, VEE.DE has a market cap of 31.6B. Regarding current trading prices, 4LL.F is priced at €7.06, while VEE.DE trades at €186.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas VEE.DE's P/E ratio is 49.00. In terms of profitability, 4LL.F's ROE is -0.68%, compared to VEE.DE's ROE of +0.13%. Regarding short-term risk, 4LL.F is more volatile compared to VEE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, QY1.F has a market cap of 1.5B. Regarding current trading prices, 4LL.F is priced at €7.06, while QY1.F trades at €22.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas QY1.F's P/E ratio is -246.67. In terms of profitability, 4LL.F's ROE is -0.68%, compared to QY1.F's ROE of -0.01%. Regarding short-term risk, 4LL.F is more volatile compared to QY1.F. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, NXU.DE has a market cap of 1.2B. Regarding current trading prices, 4LL.F is priced at €7.06, while NXU.DE trades at €71.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas NXU.DE's P/E ratio is 37.62. In terms of profitability, 4LL.F's ROE is -0.68%, compared to NXU.DE's ROE of +0.12%. Regarding short-term risk, 4LL.F is more volatile compared to NXU.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, COP.DE has a market cap of 1.2B. Regarding current trading prices, 4LL.F is priced at €7.06, while COP.DE trades at €22.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas COP.DE's P/E ratio is 43.58. In terms of profitability, 4LL.F's ROE is -0.68%, compared to COP.DE's ROE of +0.04%. Regarding short-term risk, 4LL.F is more volatile compared to COP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, AJ91.DE has a market cap of 58.9M. Regarding current trading prices, 4LL.F is priced at €7.06, while AJ91.DE trades at €11.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas AJ91.DE's P/E ratio is 11.25. In terms of profitability, 4LL.F's ROE is -0.68%, compared to AJ91.DE's ROE of +0.14%. Regarding short-term risk, 4LL.F is more volatile compared to AJ91.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, M3V.DE has a market cap of 44.4M. Regarding current trading prices, 4LL.F is priced at €7.06, while M3V.DE trades at €24.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas M3V.DE's P/E ratio is -174.29. In terms of profitability, 4LL.F's ROE is -0.68%, compared to M3V.DE's ROE of +0.15%. Regarding short-term risk, 4LL.F is more volatile compared to M3V.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, IS8.DE has a market cap of 7.3M. Regarding current trading prices, 4LL.F is priced at €7.06, while IS8.DE trades at €2.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas IS8.DE's P/E ratio is -0.83. In terms of profitability, 4LL.F's ROE is -0.68%, compared to IS8.DE's ROE of +0.05%. Regarding short-term risk, 4LL.F is more volatile compared to IS8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, U9O0.F has a market cap of 863.9K. Regarding current trading prices, 4LL.F is priced at €7.06, while U9O0.F trades at €0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas U9O0.F's P/E ratio is -1.60. In terms of profitability, 4LL.F's ROE is -0.68%, compared to U9O0.F's ROE of -0.82%. Regarding short-term risk, 4LL.F is more volatile compared to U9O0.F. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, NMI.DE has a market cap of 206.2K. Regarding current trading prices, 4LL.F is priced at €7.06, while NMI.DE trades at €0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas NMI.DE's P/E ratio is N/A. In terms of profitability, 4LL.F's ROE is -0.68%, compared to NMI.DE's ROE of +0.55%. Regarding short-term risk, 4LL.F is more volatile compared to NMI.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 4LL.F.

4LL.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4LL.F stands at 1.2B. In comparison, MDQK.HM has a market cap of 0. Regarding current trading prices, 4LL.F is priced at €7.06, while MDQK.HM trades at €7.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4LL.F currently has a P/E ratio of -1.36, whereas MDQK.HM's P/E ratio is N/A. In terms of profitability, 4LL.F's ROE is -0.68%, compared to MDQK.HM's ROE of -0.07%. Regarding short-term risk, 4LL.F is less volatile compared to MDQK.HM. This indicates potentially lower risk in terms of short-term price fluctuations for 4LL.F.